BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16172460)

  • 1. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
    Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
    J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
    Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; Carey LA; Grundy PE; Perlman EJ; Breslow NE; Sukumar S
    Cancer Res; 1999 Sep; 59(17):4301-7. PubMed ID: 10485476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma.
    Sotobori T; Ueda T; Oji Y; Naka N; Araki N; Myoui A; Sugiyama H; Yoshikawa H
    Cancer; 2006 May; 106(10):2233-40. PubMed ID: 16607650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
    Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
    Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hTERT mRNA levels by real-time RT-PCR in acute myelogenous leukemia.
    Huh HJ; Huh JW; Yoo ES; Seong CM; Lee M; Hong KS; Chung WS
    Am J Hematol; 2005 Aug; 79(4):267-73. PubMed ID: 16044449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors.
    Ohali A; Avigad S; Cohen IJ; Meller I; Kollender Y; Issakov J; Gelernter I; Goshen Y; Yaniv I; Zaizov R
    J Clin Oncol; 2003 Oct; 21(20):3836-43. PubMed ID: 14551302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
    Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
    Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.
    Tabori U; Ma J; Carter M; Zielenska M; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
    J Clin Oncol; 2006 Apr; 24(10):1522-8. PubMed ID: 16575002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased microvascular density predicts relapse in Wilms' tumor.
    Abramson LP; Grundy PE; Rademaker AW; Helenowski I; Cornwell M; Katzenstein HM; Reynolds M; Arensman RM; Crawford SE
    J Pediatr Surg; 2003 Mar; 38(3):325-30; discussion 325-30. PubMed ID: 12632343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
    Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
    Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
    Luzar B; Poljak M; Fischinger J; Klopcic U; Gale N
    J Laryngol Otol; 2005 Nov; 119(11):917-21. PubMed ID: 16354348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 expression in Wilms' tumor: a possible role as prognostic factor.
    Beniers AJ; Efferth T; Füzesi L; Granzen B; Mertens R; Jakse G
    Int J Oncol; 2001 Jan; 18(1):133-9. PubMed ID: 11115550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase expression predicts unfavorable outcome in osteosarcoma.
    Sanders RP; Drissi R; Billups CA; Daw NC; Valentine MB; Dome JS
    J Clin Oncol; 2004 Sep; 22(18):3790-7. PubMed ID: 15365076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.
    Yokoi S; Yasui K; Iizasa T; Imoto I; Fujisawa T; Inazawa J
    Clin Cancer Res; 2003 Oct; 9(13):4705-13. PubMed ID: 14581340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer].
    Li LR; Wan DS; Pan ZZ; Hardingham J; Rieger N; Hewett P; Zhou ZW; Chen G
    Ai Zheng; 2004 Nov; 23(11 Suppl):1502-7. PubMed ID: 15566667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.